Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Glenmark Pharmaceuticals: Board Meeting Outcome for Board Meeting Outcome - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026
News Announcement

Glenmark Pharmaceuticals: Board Meeting Outcome for Board Meeting Outcome - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026

31-Jul-2026 Follow Value Research Online on Google download pdfDownload PDF Glenmark Pharmaceuticals

The Board of Directors has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.